Literature DB >> 8814068

Local disruption of the insulin-like growth factor system in the arthritic joint.

J K Fernihough1, M E Billingham, S Cwyfan-Hughes, J M Holly.   

Abstract

OBJECTIVE: To identify differences in levels of insulin-like growth factor (IGF) and IGF binding proteins (IG-FBPs) between 30 patients with arthritis (14 with rheumatoid arthritis [RA], 16 with osteoarthritis [OA]) and 11 normal control subjects. IGF and IGFBP levels were correlated to the disease activity marker C-reactive protein (CRP) to determine whether they were disease related. We also examined the degree of proteolytic modification of the IGFBPs.
METHODS: Radioimmunoassays were used for measuring IGF and IGFBP-3 levels; CRP was measured by enzyme-linked immunosorbent assay. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western blotting, chemiluminescence, and autoradiography were used for visualizing binding proteins.
RESULTS: There was a significant increase in synovial fluid levels of both IGF-1 and IGFBP-3 in both RA and OA. This resulted in an elevated IGFBP-3 to IGF molar ratio of 1.49 in the OA group and 1.47 in the RA group, compared with 0.86 in the normal control group (P = 0.0002 for both). A significantly lower degree of IGFBP-3 proteolysis was also seen in the synovial fluids from the patients compared with the controls. There were significant correlations between the CRP level and levels of IGF-1, IGF-2, and IGFBP-3 in the RA patients (r = 0.62-0.898, P = 0.04-0.0007).
CONCLUSION: There was significant local disruption of the IGF system in patients with arthritis. This may result in a lower amount of IGF that is able to bind to IGF receptors in the arthritic joint. Levels of IGF-1 IGF-2, and IGFBP-3 all correlated with the CRP level in patients with RA, which indicates the possibility that the IGF system is involved in the disease process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814068     DOI: 10.1002/art.1780390916

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis.

Authors:  J A Martin; M B Scherb; L A Lembke; J A Buckwalter
Journal:  Iowa Orthop J       Date:  2000

Review 2.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

3.  Transforming growth factor-beta1 modulates insulin-like growth factor binding protein-4 expression and proteolysis in cultured periosteal explants.

Authors:  Carlos Gonzalez; Kiem G Auw Yang; Joseph H Schwab; James S Fitzsimmons; Monica M Reinholz; Zachary T Resch; Laurie K Bale; Victoria R Clemens; Cheryl A Conover; Shawn W O'Driscoll; Gregory G Reinholz
Journal:  Growth Horm IGF Res       Date:  2009-08-04       Impact factor: 2.372

4.  Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid.

Authors:  W H Busby; S A Yocum; M Rowland; D Kellner; S Lazerwith; F Sverdrup; M Yates; M Radabaugh; D R Clemmons
Journal:  Osteoarthritis Cartilage       Date:  2008-10-18       Impact factor: 6.576

5.  Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population.

Authors:  Mikkel Andreassen; Ilan Raymond; Per Hildebrandt; Caroline Kistorp; Camilla Rathcke; Henrik Vestergaard; Jens Faber; Lars Ostergaard Kristensen
Journal:  Inflamm Res       Date:  2010-01-03       Impact factor: 4.575

6.  IGFBP-5 Metabolism Is Disrupted in the Rat Medial Meniscal Tear Model of Osteoarthritis.

Authors:  Matthew P Yates; Steven L Settle; Sue A Yocum; Poonam Aggarwal; Lillian E Vickery; Dean J Aguiar; Adam P Skepner; Debra Kellner; Scott L Weinrich; Francis M Sverdrup
Journal:  Cartilage       Date:  2010-01       Impact factor: 4.634

Review 7.  Insulin-Like Growth Factor Binding Proteins in Autoimmune Diseases.

Authors:  Huihua Ding; Tianfu Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-30       Impact factor: 5.555

8.  Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity.

Authors:  Hanna Lee; Young Sun Suh; Sang-Il Lee; Yun-Hong Cheon; Mingyo Kim; Hae Sook Noh; Hyun-Ok Kim
Journal:  BMC Res Notes       Date:  2022-04-05

9.  Pharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytes.

Authors:  Frédéric De Ceuninck; Audrey Caliez; Laurent Dassencourt; Philippe Anract; Pierre Renard
Journal:  Arthritis Res Ther       Date:  2004-06-28       Impact factor: 5.156

10.  Insulin-Like Growth Factor Binding Protein 6 in Rheumatoid Arthritis: A Possible Novel Chemotactic Factor?

Authors:  Alessia Alunno; Onelia Bistoni; Mirko Manetti; Giacomo Cafaro; Valentina Valentini; Elena Bartoloni; Roberto Gerli; Arcangelo Liso
Journal:  Front Immunol       Date:  2017-05-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.